These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11168725)

  • 1. Isolation of human faecal bifidobacteria which reduce signs of Salmonella infection when orogastrically dosed to mice.
    Henriksson A; Conway PL
    J Appl Microbiol; 2001 Feb; 90(2):223-8. PubMed ID: 11168725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and translocation assay to study the protective capacity of Bifidobacterium lactis INL1 against Salmonella Typhimurium infection in mice.
    Zacarías MF; Reinheimer J; Forzani L; Grangette C; Vinderola G
    Benef Microbes; 2014 Dec; 5(4):427-36. PubMed ID: 24902954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides.
    Asahara T; Nomoto K; Shimizu K; Watanuki M; Tanaka R
    J Appl Microbiol; 2001 Dec; 91(6):985-96. PubMed ID: 11851805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the intestinal microbiota of oligosaccharide fed mice exhibiting reduced resistance to Salmonella infection.
    Petersen A; Bergström A; Andersen JB; Hansen M; Lahtinen SJ; Wilcks A; Licht TR
    Benef Microbes; 2010 Sep; 1(3):271-81. PubMed ID: 21831764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of bifidus milk on the experimental infection with Salmonella enteritidis subsp. typhimurium in conventional and gnotobiotic mice.
    Silva AM; Bambirra EA; Oliveira AL; Souza PP; Gomes DA; Vieira EC; Nicoli JR
    J Appl Microbiol; 1999 Feb; 86(2):331-6. PubMed ID: 10063632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity.
    Liévin V; Peiffer I; Hudault S; Rochat F; Brassart D; Neeser JR; Servin AL
    Gut; 2000 Nov; 47(5):646-52. PubMed ID: 11034580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice.
    Silva AM; Barbosa FH; Duarte R; Vieira LQ; Arantes RM; Nicoli JR
    J Appl Microbiol; 2004; 97(1):29-37. PubMed ID: 15186439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell viability and immunostimulating and protective capacities of Bifidobacterium longum 51A are differentially affected by technological variables in fermented milks.
    Souza TC; Zacarías MF; Silva AM; Binetti A; Reinheimer J; Nicoli JR; Vinderola G
    J Appl Microbiol; 2012 Jun; 112(6):1184-92. PubMed ID: 22394272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of a candidate probiotic strain of Pediococcus pentosaceus from the faecal microbiota of horses by in vitro testing and health claims in a mouse model of Salmonella infection.
    Silva BC; Sandes SH; Alvim LB; Bomfim MR; Nicoli JR; Neumann E; Nunes AC
    J Appl Microbiol; 2017 Jan; 122(1):225-238. PubMed ID: 27813217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice.
    Searle LEJ; Best A; Nunez A; Salguero FJ; Johnson L; Weyer U; Dugdale AH; Cooley WA; Carter B; Jones G; Tzortzis G; Woodward MJ; La Ragione RM
    J Med Microbiol; 2009 Jan; 58(Pt 1):37-48. PubMed ID: 19074651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature Salmonella Typhimurium growth inhibition in competition with other Gram-negative organisms is redox potential regulated via RpoS induction.
    Komitopoulou E; Bainton NJ; Adams MR
    J Appl Microbiol; 2004; 97(5):964-72. PubMed ID: 15479411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vitro antagonism and of in vivo immune modulation and protection against pathogenic experimental challenge of two probiotic strains of Bifidobacterium animalis var. lactis.
    Martins AK; Martins FS; Gomes DA; Elian SD; Vieira AT; Teixeira MM; Cara DC; Nardi RM; Nicoli JR
    Arch Microbiol; 2010 Dec; 192(12):995-1003. PubMed ID: 20848082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.
    Rodrigues AC; Nardi RM; Bambirra EA; Vieira EC; Nicoli JR
    J Appl Bacteriol; 1996 Sep; 81(3):251-6. PubMed ID: 8810053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice.
    Gagnon M; Kheadr EE; Dabour N; Richard D; Fliss I
    Int J Food Microbiol; 2006 Aug; 111(1):26-33. PubMed ID: 16822570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Lactobacillus plantarum Tennozu-SU2 on Salmonella Typhimurium Infection in Human Enterocyte-Like HT-29-Luc Cells and BALB/c Mice.
    Hirano S; Yokota Y; Eda M; Kuda T; Shikano A; Takahashi H; Kimura B
    Probiotics Antimicrob Proteins; 2017 Mar; 9(1):64-70. PubMed ID: 27943051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant effect of a probiotic fermented milk in the protection against Salmonella enteritidis serovar typhimurium infection: mechanisms involved.
    De Moreno De Leblanc A; Maldonado Galdeano C; Dogi CA; Carmuega E; Weill R; Perdigón G
    Int J Immunopathol Pharmacol; 2010; 23(4):1235-44. PubMed ID: 21244773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Saccharomyces yeasts protect against epithelial cell barrier disruption induced by Salmonella enterica subsp. enterica serovar Typhimurium.
    Smith IM; Baker A; Arneborg N; Jespersen L
    Lett Appl Microbiol; 2015 Nov; 61(5):491-7. PubMed ID: 26280244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of normal microflora on the course of experimental infection].
    Gorbunova ML; Tsivinskaia MA; Tret'iakova IN; Lobanova EI
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):110-3. PubMed ID: 4595599
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticlostridial agent 8-hydroxyquinoline improves the isolation of faecal bifidobacteria on modified Wilkins-Chalgren agar with mupirocin.
    Novakova J; Vlkova E; Salmonova H; Pechar R; Rada V; Kokoska L
    Lett Appl Microbiol; 2016 Apr; 62(4):330-5. PubMed ID: 26849418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of colonisation resistance in stool of human donors using ex vivo, in vitro and in vivo assays.
    Galvão MF; Bastos RW; Acurcio LB; Nascimento BB; Sandes SHC; Arantes RME; Souza MR; Martins FS; Vieira LQ; Nicoli JR
    Benef Microbes; 2017 Apr; 8(2):217-230. PubMed ID: 28116929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.